St.

Anthony’s College
Nursing Department

DRUG STUDY
Name of patient: Ms. N.D. Attending Physician: Dr. S
Age: 60 years old Impression Diagnosis: Tamponade, Cardiac
Name of Drug Dosage, Route, Mechanism of Indication Side Effects: Special Precautions Nursing Responsibilities
Freq., Timing Action
Generic: Dosage: Mainly stimulates Improve heart CNS: Anxiety, headache, - Avoid use in patients with - Observe 14 rights of
Dobutamine 2.5 to 10 beta1-adrenergic function during dizziness, fatigue atrial fibrillation, medication administration.
mcg/kg/min receptors, and mildly tamponade. CV: Palpitations, tachycardia, hypertension, CAD, MI, - Continuously monitor for
Brand: stimulates beta2- and hypo/hypertension, PVCs, hypovolemia, cardiac rate or arrhythmias.
Dobutrex Route: alpha1-adrenergic angina dysrhythmias, sulfite - Maintain accurate I&O
IV receptors.Can ENDO: Hypokalemia hypersensitivity, renal and measure urinary output
increased GI: Heartburn, nausea, failure, breastfeeding frequently.
contractility, vomiting - Monitor BP and pulse
Frequency: increased cardiac MS: Muscle cramps (leg) q5min during infusion; if
Does not extend output without RESP: Dyspnea BP drops 30 mmHg, stop
Classification: 48 hours of marked increase in Contraindications Adverse Reactions infusion and call the
Pharmacother repeated heart rate by acting - Hypersensitivity - Overdose may produce prescriber.
apeutic: continuous on B1-receptors in to dobutamine or severe tachycardia - Monitor hemodynamic
Adrenergic infusion. heart; minor α/B2 its components. - Severe hypertension parameters, such as central
agonist effects. Increased - Hypertrophic venous pressure,
Timing: myocardial cardiomyopathy pulmonary artery wedge
Clinical: continuous contractility raises with outflow pressure, and cardiac
Cardiac infusion coronary blood flow obstruction. output, as indicated, to
Stimulant and myocardial assess drug’s effectiveness.
oxygen - Monitor serum potassium
Chemical: consumption. Other level to check for
Catecholamine hemodynamic effects hypokalemia, a rare result
include decreased of beta 2 stimulation that
systemic vascular causes electrolyte
resistance, which imbalance.
reduces afterload, - Monitor for sulfite
and decreased sensitivity which may be
ventricular filling life threatening.
pressure, which - Immediately notify
reduces preload. physician of decreased
urinary output, cardiac
 Therapeutic arrhythmias, significant
outcome: increased in BP, heart rate
Cardiac output or less commonly
increased with hypotension.
decreased fatigue - Teach the patient about
and dyspnea. the purpose of medication
and expected results;
reason for all monitoring
and procedures.
- Advise patients to report
dyspnea, headache, IV site
discomfort, chest pain and
numbness of extremities.
Student’s Name: Cyril Joy N. Fernando BSN 3A

References:

Jones & Bartlett Learning (2015). Nurse’s Drug Handbook.

Kizior & Hodgson (2019). Saunders Nursing Drug Handbook. Elsevier.
Skidmore-Roth (2015). Mosby’s Drug Guide for Nursing Students Eleventh Edition. Elsevier Mosby.